Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Clinical trial NCT00803062 · COMPLETED

Trial details

NCT number: NCT00803062
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage IVB Cervical Cancer

Start date: 2009-04-01
Primary completion: 2013-02-01
Enrollment: 452

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.